glp 1 agonists moa Mechanisms of Action and Therapeutic Application of Glucagon-like Peptide-1 Mechanism of action of GLP-1

Important: Prescription GLP-1 treatments require medical supervision, involve injections, and come with potential side effects

Excited to get started and enjoy health benefits like never before

They are not approved for human or veterinary use

For instance: people with obesity are more likely to develop type 2 diabetes people with obesity are at an increased riskof developing Alzheimers later in life people with type 2 diabetes are also more likely to develop Alzheimers disease Alzheimers disease is associated with insulin resistance in the brain, with some scientists referring to Alzheimers as type 3 diabetes obesity, type 2 diabetes, and Alzheimers all involve inflammation, and GLP-1 agonists have an anti-inflammatory effect studies in animal models of dementiahave shown that GLP-1 agonists can protect rats brains from damage